• Tidak ada hasil yang ditemukan

Supplementary Table eTable 1: Patient Clinical information

N/A
N/A
Protected

Academic year: 2023

Membagikan "Supplementary Table eTable 1: Patient Clinical information"

Copied!
4
0
0

Teks penuh

(1)

Supplementary Table

eTable 1: Patient Clinical information

ID# Hemisphere Onset

Handedness Sex Age Onset (Years)

Epilepsy duration (Years)

Age at Scan (Years)

Medications Etiology and

MRI Findings

Location EEG IED Epilepsy Type

1 Left Ambidextrous F 0.8 12.0 12.8 Clobazam, lacosamide Vascular

malformation;

AVM

Frontal Pole* Bifrontal polyspike/spike slow wave; GPFA; 3 EC seizure biF with possible left>right onset

Focal unaware

2 Left Ambidextrous M 7.0 11.6 18.6 Oxcarbazepine, valproate,

levetiracetam, guanfacine, focalin, vayarin

FCD deep asymetric digitatied sulcus

Frontal; frontal temporal junction

Frequent spike-waves bi-frontal shifting L or R, L temporal, intermittent slow FT

Focal unaware with secondary generalization

3 Left Ambidextrous M 12.0 2.7 14.7 Lamotrigine Tumor Temporal; Mesial

Anterior

Lat spike-wave Focal unaware

4 Left Ambidextrous F 3.0 4.0 7.0 Valproate, levetiracetam FCD, MTS Temporal Pole* Frequent left anterior temporal discharges Focal unaware with secondary generalized seizure

5 Left Left F 0.3 7.1 7.3 Levetiracetam, trileptal FCD Frontal;

Precentral Motor*

C3 focal discharges Focal unaware

w/ motor manifestations

6 Left Left M 2.0 12.9 14.9 Dextroamphetamine,

levetiracetam, valproate, lacosamide

FCD Frontal pole Bilateral independent fronto-temporal discharges Focal epilepsy unaware with secondary generalization

7 Left Left M 15.0 1.5 16.5 Levetiracetam Tumor Temporal;

Posterior*

No definite epileptiform activity was seen Focal unaware

8 Left Left F 4.0 7.3 11.3 Lamotrigine, fluoxetine,

oxcarbazepine, valproate

Vascular;

MCA stroke

Frontal, corona radiata, putamen, and insula

Frequent discharges over left posterior head regions P3/T5; Delta slow in left posterior head regions

Focal unaware epilepsy w/

secondary motor manifestations

9 Left Left M 8.0 2.7 10.7 Oxcarbazepine,

levetiracetam

FCD Posterior

Temporal*

Sharp waves at T3, T5, F3 (mostly T5) (some F7/F3, Fp1/F7, T5/O1)

Focal unaware epilepsy w/

secondary motor manifestations

10 Left Left M 0.0 13.5 13.5 Lamotrigine, levetiracetam Encephalomal

acia

Mesial Temporal* Left anterior temporal slowing; Epileptiform discharges from left temporal area F7/T3/T5

Focal epilepsy with impaired consciousness with 2nd generalization

11 Left Right M 4.0 7.6 11.6 Levetiracetam FCD Temporal, Mesial;

Insula; Central Sulcus

Occasional left central/parietal/temporal sharps, left posterior temporal/parietal slowing; several seizures captured arising from left posterior temporal/

centroparietal areas (lateralized not localized)

Focal with alteration in awareness

12 Left Right M 12.0 1.7 13.7 Levetiracetam, lorazepam,

topiramate

MCD Temporal,

Posterior Insula/Parietal

T3/T5/O1 spreading to P3 sharp waves Focal with and without impaired consciousness

13 Left Right F 13.0 0.3 13.3 None Vascular;

AVM

Inferior Frontal Consistent diffuse slowing Focal unaware with secondary generalization

14 Left Right F 17.0 0.2 17.2 Levetiracetam Tumor Temporal Pole* Independent left anterior and mid temporal discharges

during sleep

Focal with alteration in awareness

15 Left Right F 15.0 0.6 15.6 Levetiracetam,

oxcarbazepine

Tumor Inferior-Frontal 1/15 slowing LF F7 Focal with alteration in awareness

16 Left Right F 13.0 0.4 13.4 Levetiracetam, loratadine Tumor Middle Temporal

Gyrus*

Not available for review Focal with alteration in awareness

17 Left Right M 8.0 5.3 13.3 Levetiracetam, lamotrigine Genetic

abnormality

Mesial Frontal, Cingular, Orbitofrontal

Bi-frontal spike-waves, shifting laterality L>R Focal epilepsy with impaired consciousness with secondary generalization

18 Left Right M 2.0 12.6 14.6 Oxcarbazepine, lacosamide MCD Frontal; Posterior

Insular

No clear interictal discharges. EEG onset consists of left frontal polar/frontal slowing and settles into clear spike and slow wave discharges in the left anterior temporal region

Focal epilepsy with impaired consciousness with secondary generalization

19 Left Right M 6.0 9.7 15.7 Pregabalin, lamotrigine,

guanfacine, rufinamide

FCD Posterior

Temporal

Frequent left anterior, mid-temporal and posterior temporal spike waves, most prominently in the left posterior temporal area

Focal with impaired awareness

20 Left Right F 9.0 0.2 9.2 None Vascular;

AVM

Posterior Temporal*

Symmetrical irregular 2-3Hz activity in bilateral posterior regions

Focal with impaired awareness

21 Left Right M 15.0 0.9 15.9 Clonazepam, levetiracetam Tumor Mesial & Anterior

Temporal Lobe*

Left temporal sharps Focal with impaired awareness

(2)

22 Left Right F 0.3 8.3 8.7 Levetiracetam, oxcarbazepine

FCD, MTS MTS Anterior Temporal Lobe*

Slowing in left hemisphere, especially left centrotemporal (shifting at either T5 or broad at C3/P3/T5)

Focal with or without secondary generalized seizures

23 Left Right M 14.0 2.1 16.1 Oxcarbazepine, lacosamide FCD Posterior

Superior Frontal Gyrus*

Generalized spike-wave shifting laterality; occ left temporal T5 spike-wave, bilateral FT spike-wave prominent Right; photoparoxysmal response (off meds)

Focal with secondary generalized

24 Right Ambidextrous M 14.0 0.4 14.4 Dextroamphetamine,

oxcarbazepine

FCD Medial frontal,

cingulate

No clear interictal discharges. Febrile seizures

25 Right Right M 10.0 6.6 16.6 Valproate, levetiracetam Genetic

Abnormality

Temporal Bilateral central independent R>L, sharp and slow- wave complexes occurring during light sleep and drowsiness

Focal aware with sensory-motor features

26 Right Right F 1.3 12.4 13.6 Oxcarbazepine, lacosamide FCD Parietal; Sensory

Cortex

Frequent biparietal/midline (greater R) spikes Focal unaware

27 Right Right M 3.5 11.7 15.2 Carbamazepine,

lacosamide

FCD Superior Frontal

Sulcus*

Frequent bifrontal sharps, right frontal onset. Focal unaware with secondary generalization

28 Right Right F 7.0 0.6 7.6 Levetiracetam Tumor Parietal Posterior

to Motor Strip*

Focal slowing right parietal region Focal unaware

29 Right Right F 0.0 12.5 12.5 Oxcarbazepine,

lacosamide, topiramate

Encephalomal acia

Parietal and Mesial Occipital *

Frequent discharge over right hemisphere independent and rare left frontal; Occasional right centro-temporal discharge

Complex partial epilepsy

30 Right Right M 7.0 3.5 10.5 Valproate, lacosamide,

oxcarbazepine

Nonlesional Frontal Unilateral focal discharge from right frontal region F4 Fp2 F8

Focal unaware

31 Right Right F 12.0 4.7 16.7 Levitiracetam, lacosamide,

folic acid, acetylsalicylic acid, B vitamin

Tumor Frontal One nocturnal electrographic seizure emanating from the right frontal region F4 Fp2 F8

Focal unaware

Note: * Under location, indicates the patient had surgery in this brain region.

(3)

eFigure 1. Frontal Epilepsy Foci Group: Raw values of frontal and temporal raw values by hemisphere against age

Left Right Frontal

Integration (raw FCi)

Temporal Integration

(raw FCi)

M EA N VERT EX VA LUE

AGE (YEARS)

Frontal Segregation

(raw FCs)

Temporal Segregation

(raw FCs)

Left R2 Linear=0.06 Right R2 Linear = 0.08

Left R2 Linear=0.10 Right R2 Linear = 0.20 Left R2 Linear=0.35

Right R2 Linear = 0.15

Left R2 Linear=0.18

Right R2 Linear = 0.08

(4)

eFigure 2. Group Maps of Integration and Segregation for the Frontal and Temporal Epilepsy Foci Group

Frontal Foci Intra

Temporal Foci Intra

Frontal Foci Inter

Temporal Foci

Inter

Referensi

Dokumen terkait

In extending previous work9 we demonstrate the ongoing declines in youth smoking in the context of more than two decades of comprehensive tobacco control in Australia including peak

Participation in Sport Internal Assets Commitment to Learning Achievement motivation School engagement Positive Values Equity and social justice Social Competencies Planning and